Please assess the completion status of the following clinical trial:

Trial Title: BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon® by Using Elements of the BetaPlus Program

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Relapsing-remitting MS (RRMS) or secondary-progressive MS (SPMS)~* Previous treatment with disease modifying drugs~* Adjustment of disease modifying treatment necessary at the discretion of the investigator~* Switch to Betaferon at least 1 month but not longer than 3 months prior to inclusion~Exclusion Criteria:~* Patients not fulfilling the indications in the local prescribing information~* Refusal to sign inform consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group 1 (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).